Outstanding Talent, Outstanding Management
Metabolon has assembled a group of talented, experienced managers to develop and execute its business plan. We also have an impressive staff that includes specialists in biochemistry, mass spectrometry, informatics and software development.
Rohan F. Hastie, PhD
President & Chief Executive Officer
Dr. Hastie has served as president and CEO at Metabolon since May 2018. He joined the company in 2017 as chief business officer to oversee critical strategic initiatives within the Company's precision medicine, population health, and pharmaceutical and life sciences services business units and guide global commercial development. Prior to joining Metabolon, he was president of Arrow Life Sciences & Healthcare, a consulting firm specializing in commercialization and operational excellence for life sciences companies. Prior to that, he held various senior leadership positions in diagnostics and corporate development at Hologic, Inc., including president of Hologic Diagnostics. Before Hologic, Dr. Hastie worked at the strategy consulting company PA Consulting Group in their Life Sciences and Technology group, where he consulted for a wide range of companies in the pharmaceutical, biotechnology and diagnostics industries. He has a PhD in molecular genetics from Queen Elizabeth Medical School in Birmingham UK and a degree in biological sciences from the University of Birmingham.
Stephen J. Furlong, M.S.
Senior Vice President, Finance & Corporate Secretary
Mr. Furlong is a commercially focused finance executive with over 32 years of experience spanning four different industries. Prior to joining Metabolon, he was CFO at Rapid Micro Biosystems, a creator of innovative products for fast, accurate detection of microbial contamination. Prior to that, Mr. Furlong served as Senior Vice President, Finance and Sales Administration, at Hologic, Inc., a global leader in women's health solutions. Prior to his 14 years at Hologic, he served in various finance roles at Safety 1st, Stratus Computer, Inc. and Raytheon Company. He has a Master of Science in Finance degree from Bentley University and a BA in political science from The Pennsylvania State University.
William A. Pettit
Senior Vice President, Human Resources
Mr. Pettit is a human resources executive with proven abilities as a change agent building high-performance organizations and developing management teams. He has in-depth expertise in strategic human resources planning, organization development and talent acquisition and management. After graduating from Amherst College, he began his career with the Bristol Myers Company, where he held progressively more senior roles during an 11-year tenure. He then served as Senior Vice President of Human Resources & Administration for Pharmacia (now Pfizer) supporting the Americas. He moved into the biotechnology industry in 1996, accepting responsibility as Senior Vice President of Human Resources for Ligand Pharmaceuticals. Most recently, he served as Vice President of Human Resources & Administration for Intrexon Corporation.
Sandra Merkel DeJames, PhD
Vice President, Innovation and Commercial Development
Dr. Merkel DeJames leads Metabolon’s Precision Medicine group. She has international business experience across several industries, including pharmaceuticals, diagnostics, agriculture, energy and life sciences, and has broad experience in biotechnology, including direct research, early-stage commercialization and new technology development. Prior to Metabolon, Dr. Merkel DeJames was Head of Regional Development (Americas region) for Novozymes leading market strategy development and global commercialization for new products and technologies. While there, she also played a role in developing a novel therapeutic cell-based technology to address next-generation market needs. Dr. Merkel DeJames serves on various boards and advisory councils, including the National Advisory Board for the NCSU Institute of Emerging Issues and the North Carolina Center of Innovation Networks. She holds a PhD in biology and completed her post-doctoral training at the UNC School of Medicine.
Vice President, Marketing
Mrs. Johnson serves as Metabolon’s Vice President of Marketing, leading global brand strategy, demand generation, and marketing communications. Before joining Metabolon, Mrs. Johnson held the title of Vice President of Marketing for Patheon, a Thermo Fisher Scientific company. She also held senior leadership roles with Covance Laboratories and Baxter Healthcare. Mrs. Johnson received her MBA from Northwestern University’s Kellogg School of Management and her BA from Marquette.
President, International Business
Michael Rasche is Metabolon’s President of International Business and a member of the corporate executive team. His track record in international business expansion in Pharma, Diagnostics, and Biotech contributes to advancing Metabolon's position as the world leader in metabolomics. Mr. Rasche brings 28 years of experience in the healthcare and life science arena, with a focus on the interface between Pharma and Diagnostics. Before Metabolon, Mr. Rashce serves as the Chief Commercial Officer at Definiens. Prior to Definiens, Mr. Rasche was Corporate Vice President of Global Commercial Operations at Ayoxxa. He has also held leadership positions with Dako (today Agilent), Roche and Bayer Diagnostics both in Europe and the Americas across nine different countries.
Vice President, Sales
Charles (Chuck) Wayland is an experienced sales executive with a demonstrated history of success working in the biotechnology industry. His expertise spans multiple life sciences disciplines, including metabolomics, genomics, diagnostics, proteomics, and personalized medicine. Before joining Metabolon, Mr. Wayland was Vice President of Sales at Progentity, managing the company’s genetic testing portfolio. Before that, he held the position as Vice President of North American Sales for Qiagen. Mr. Wayland has also held senior roles at Digene and Applied Imaging. He earned his BS in Management from Texas Tech University.